Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France

被引:66
作者
Damond, F
Apetrei, C
Robertson, DL
Souquière, S
Leprêtre, A
Matheron, S
Plantier, JC
Brun-Vézinet, F
Simon, F
机构
[1] CHU Charles Nicolle, Virol Lab, F-76031 Rouen, France
[2] Hop Bichat Claude Bernard, Virol Lab, F-75877 Paris 18, France
[3] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, F-75877 Paris 18, France
[4] Ctr Int Rech Med Franceville, Virol Lab, Franceville, Gabon
[5] CNRS, UMR 1889, F-13402 Marseille 20, France
关键词
D O I
10.1006/viro.2000.0685
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine the prevalence of human immunodeficiency virus type 2 (HIV-2) subtypes circulating in France and to identify possible relationships between these subtypes and pathogenesis, we studied 33 HIV-2-infected patients living in France. HIV-2 DNA was directly amplified from peripheral blood mononuclear cells by nested PCR with specific HIV-2 env primers, and the env gene was sequenced. The serological consequences of antigenic variability were studied by using a panel of peptides and by Western blotting. Phylogenetic analysis classified the 33 HIV-2 strains as subtype A (n = 23) or B (n = 10). There were no significant clinical or epidemiological differences between patients infected with either of these two subtypes. There was some evidence for geographical clustering. Subtype A strains from patients originating from the Cape Verde Islands and Guinea Bissau clustered together. The majority of patients infected with subtype a strains originated from the Ivory Coast or Mall. Strains from patients originating in Mall also clustered in subtype A but distinctly from the Cape Verde or Guinea Bissau strains. The subtype B strains showed greater diversity and included some highly divergent strains relative to those previously characterized. The V3 loop of HIV-2 subtypes A and B was found to be quite conserved in comparison with HIV-1. A strong HIV-2 subtype a serological cross-reactivity was found on HIV-1 env antigen by Western blot mostly in the gp41 transmembrane glycoprotein. This could partly explain the double HIV-1 and HIV-2 reactive profiles found in countries where HIV-2 subtype B is prevalent. (C) 2001 Academic Press.
引用
收藏
页码:19 / 30
页数:12
相关论文
共 38 条
[1]  
ANCELLE R, 1987, LANCET, V1, P688
[2]   INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION [J].
BOERI, E ;
GIRI, A ;
LILLO, F ;
FERRARI, G ;
VARNIER, OE ;
FERRO, A ;
SABBATANI, S ;
SAXINGER, WC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4546-4550
[3]  
BREUER J, 1996, J GEN VIROL, V76, P333
[4]   BIOLOGIC HETEROGENEITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) STRAINS [J].
CASTRO, BA ;
BARNETT, SW ;
EVANS, LA ;
MOREAU, J ;
ODEHOURI, K ;
LEVY, JA .
VIROLOGY, 1990, 178 (02) :527-534
[5]  
Centers for Disease Control, 1993, MMWR Morb Mortal Wkly Rep, V41, P1
[6]   Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys [J].
Chen, ZW ;
Luckay, A ;
Sodora, DL ;
Telfer, P ;
Reed, P ;
Gettie, A ;
Kanu, JM ;
Zhang, LQ ;
Sadek, RF ;
Yee, J ;
Ho, DD ;
Marx, PA .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3953-3960
[7]   Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA [J].
Damond, F ;
Loussert-Ajaka, I ;
Apetrei, C ;
Descamps, D ;
Souquière, S ;
Leprêtre, A ;
Matheron, S ;
Brun-Vézinet, F ;
Simon, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) :809-811
[8]   EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC [J].
DECOCK, KM ;
ADJORLOLO, G ;
EKPINI, E ;
SIBAILLY, T ;
KOUADIO, J ;
MARAN, M ;
BRATTEGAARD, K ;
VETTER, KM ;
DOORLY, R ;
GAYLE, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (17) :2083-2086
[9]  
Felsenstein J., 1993, Phylip: Phylogeny Interference Package
[10]   PERSISTENT INFECTION OF RHESUS MACAQUES WITH A MOLECULAR CLONE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 - EVIDENCE OF MINIMAL GENETIC DRIFT AND LOW PATHOGENETIC EFFECTS [J].
FRANCHINI, G ;
MARKHAM, P ;
GARD, E ;
FARGNOLI, K ;
KEUBARUWA, S ;
JAGODZINSKI, L ;
ROBERTGUROFF, M ;
LUSSO, P ;
FORD, G ;
WONGSTAAL, F ;
GALLO, RC .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4462-4467